参考文献
(在框内滑动手指即可浏览)
[1] Chen Q, Qiu YR, Zhang MD, et al. Clinical practice guidelines for pregnancy-associated breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [J]. Chin Med J (Engl), 2021, 134(20): 2395-2397.
[2] Amant F, Lefrère H, Borges VF, et al. The definition of pregnancy-associated breast cancer is outdated and should no longer be used [J]. Lancet Oncol, 2021, 22(6): 753-754.
[3] Jerzak KJ, Lipton N, Nofech-Mozes S, et al. Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study [J]. Breast Cancer Res Treat, 2021, 189(3): 797-806.
[4] Sun J, Lee MC. Clinical Presentation, Diagnosis and Prognosis of Pregnancy-Associated Breast Cancer [J]. Adv Exp Med Biol, 2020, 1252: 87-93.
[5] Committee on Obstetric Practice. Committee Opinion No. 723: guidelines for diagnostic imaging during pregnancy and lactation [J]. Obstet Gynecol, 2017, 130 (4): e210-e216.
[6] Robbins J, Jeffries D, Roubidoux M, et al. Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation [J]. Am J Roentgenol, 2011, 196 (3): 716-722.
[7] Torloni MR, Vedmedovska N, Merialdi M, et al. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis [J]. Ultrasound Obstet Gynecol, 2009, 33 (5): 599-608.
[8] Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy [J]. Lancet, 2012, 379 (9815): 570-579.
[9] Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients [J]. JAMA Oncol, 2015, 1 (8): 1145-1153.
[10] Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results?[J]. J Clin Pathol, 2001, 54 (10): 762-765.
[11] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology :Breast cancer, Version 6, 2020 [EB/OL].(2020-09-08) [2020-10-06]. https://www. nccn. org/professionals/physician_gls/default. aspx.
[12] Peccatori FA, Azim Ha JR, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2013, 24 (suppl 6): vi160-170.
[13] Ring AE, Smith IE, Jones A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals [J]. J Clin Oncol, 2005, 23 (18): 4192-4197.
[14] Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy [J]. N Engl J Med, 2015, 373 (19): 1824-1834.
[15] Loibl S, Han SN, Von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study [J]. Lancet Oncol, 2012, 13 (9): 887-896.
[16] Shachar SS, Gallagher K, Mcguire K, et al. Multidisciplinary management of breast cancer during pregnancy [J]. Oncologist, 2017, 22 (3): 324-334.
[17] Annane K, Bellocq JP, Brettes JP, et al. Infiltrative breast cancer during pregnancy and conservative surgery [J]. Fetal Diagn Ther, 2005, 20 (5): 442-444.
[18] American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 775: Nonobstetric surgery during pregnancy [J]. Obstet Gynecol, 2019,133: e285-e286.
[19] Arkenbosch JHC, van Ruler O, de Vries AC. Non-obstetric surgery in pregnancy (including bowel surgery and gallbladder surgery) [J]. Best Pract Res Clin Gastroenterol, 2020, 44-45: 101669.
[20] Tolcher MC, Fisher WE, Clark SL. Nonobstetric Surgery During Pregnancy [J]. Obstet Gynecol, 2018, 132(2): 395-403.
[21] Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(suppl 2): 7-47.
[22] Zagouri F, Sergentanis TN, Chrysikos D, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis [J]. Breast Cancer Res Treat, 2013, 137 (2): 349-357.
[23] Lambertini M, Martel S, Campbell C, et al. Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials [J]. Cancer, 2019, 125 (2):307-316.
[24] Azim HA Jr, Santoro L, Russell-Edu W, et al. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies [J]. Cancer Treat Rev, 2012, 38 (7): 834-842.
[25] Bae SY, Kim KS, Kim JS, et al. Neoadjuvant chemotherapy and prognosis of pregnancy-associated breast cancer: a time-trends study of the Korean breast cancer registry database[J]. J Breast Cance, 2018, 21 (4): 425-432.
[26] Reyes E, Xercavins N, Saura C, et al. Breast cancer during pregnancy: matched study of diagnostic approach, tumor characteristics, and prognostic factors[J]. Tumori, 2020, 106 (5): 378-387.
[27] Sechopoulos I, Suryanarayanan S, Vedantham S, et al. Radiation dose to organs and tissues from mammography: Monte Carlo and phantom study[J]. Radiology, 2008, 246 (2): 434-443.
[28] Ray JG, Vermeulen MJ, Bharatha A, et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes[J]. JAMA, 2016, 316 (9): 952-961.
[29] 马田雨,代文杰. 妊娠期乳腺癌诊断及治疗进展[J]. 中国实用外科杂志, 2014, 34(4): 376-378.
[30] Gentilini O, Cremonesi M, Trifirò G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer[J]. Ann Oncol, 2004, 15 (9): 1348-1351.
[31] Pandit-Taskar N, Dauer LT, Montgomery L, et al. Organ and fetal absorbed dose estimates from 99mTc-sulfurcolloid lymphoscintigraphy and sentinel node localization in breast cancer patients[J]. J Nucl Med, 2006, 47 (7): 1202-1208.
[32] Gentilini O, Cremonesi M, Toesca A, et al. Sentinel lymph node biopsy in pregnant patients with breast cancer[J]. Eur J Nucl Med Mol Imaging, 2010, 37 (1): 78-83.
[33] Upadya M, Saneesh PJ. Anaesthesia for non-obstetric surgery during pregnancy[J]. Indian J Anaesth, 2016, 60(4): 234-241.
[34] American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 171: Management of Preterm Labor[J]. Obstet Gynecol, 2016, 128(4): e155-164.
[35] Peccatori FA, Lambertini M, Scarfone G, et al. Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences[J]. Cancer Biol Med, 2018, 15 (1): 6-13.
[36] Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients[J]. Ann Oncol, 2004, 15 (1): 146-150.
[37] Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study[J]. Lancet Oncol, 2012, 13 (3): 256-264.
[38] de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients[J]. Lancet Oncol, 2018, 19 (3): 337-346.
[39] Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy[J]. Lancet Oncol, 2004, 5 (5): 283-291.
[40] 吴克瑾,陈玉芸,金玉春,等. 年轻女性早期乳腺癌病人生育相关调查研究[J]. 中国实用外科杂志,2021,41(11):1262-1268.
[41] Pistilli B, Bellettini G, Giovannetti E, et al. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding?[J].Cancer Treat Rev, 2013, 39 (3): 207-211.
[42] Griffin SJ, Milla M, Baker TE, et al. Transfer of carboplatin and paclitaxel into breast milk [J]. J Hum Lact, 2012, 28 (4): 457-459.
[43] diFlorio-Alexander RM, Slanetz PJ, Moy L, et al. ACR Appropriateness Criteria® breast imaging of pregnant and lactating women [J]. J Am Coll Radiol, 2018, 15 (11S): S263-S275.
[44] ACR Committee on Drugs and Contrast Media. Administration of contrast media to women who are breastfeeding [EB/OL].(2021-07-14)[2021-08-08]. https://www. acr. org/-/media/ACR/Files/Clinical-Resources/Contrast_Media. pdf.
[45] Leide-Svegborn S, Ahlgren L, Johansson L, et al. Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption [J]. Eur J Nucl Med Mol Imaging, 2016, 43 (5): 808-821.
[46] Johnson HM, Mitchell KB. Breastfeeding and breast cancer: managing lactation in survivors and women with a new diagnosis [J]. Ann Surg Oncol, 2019, 26 (10): 3032-3039.